SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 23rd, 2020 • Advaxis, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 21, 2020, between Advaxis, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT ADVAXIS, INC.Common Stock Purchase Warrant • January 23rd, 2020 • Advaxis, Inc. • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ___________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after July ___, 2020[1] (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July ___, 2025[2] (the “Termination Date”), but not thereafter, to subscribe for and purchase from Advaxis, Inc., a Delaware corporation (the “Company”), up to _____ shares of common stock, par value $0.001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Advaxis, Inc.Placement Agent Agreement • January 23rd, 2020 • Advaxis, Inc. • Pharmaceutical preparations • New York
